Showing results (901-910 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|May 18, 2013
Real-time monitoring of relative peptide-protein interaction strengths in the yeast two-hybrid systemRaphaela Rid, Julia Herzog, Richard H Maier, et al.
Assay and Drug Development Technologies|December 4, 2012
A high-throughput screening campaign for detection of ca(2+)-activated k(+) channel activators and inhibitors using a fluorometric imaging plate reader-based tl(+)-influx assaySusanne Jørgensen, Tino Dyhring, David T Brown, et al.
Assay and Drug Development Technologies|June 19, 2013
A high-throughput yeast assay identifies synergistic drug combinationsNikko P Torres, Anna Y Lee, Guri Giaever, et al.
Assay and Drug Development Technologies|June 19, 2013
Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylationMartin Brandt, Lawrence M Szewczuk, Hong Zhang, et al.
Assay and Drug Development Technologies|October 17, 2013
High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell linesPaul A Johnston, Malabika Sen, Yun Hua, et al.
Assay and Drug Development Technologies|October 17, 2013
Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitorsTakrima Sadikot, Megan Swink, Jeffery D Eskew, et al.
Assay and Drug Development Technologies|November 16, 2013
A fluorescence anisotropy-based Myt1 kinase binding assayAlexander Rohe, Claudia Henze, Frank Erdmann, et al.
Assay and Drug Development Technologies|August 3, 2013
A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitorsYuhong Du, Robert W Fu, Bin Lou, et al.
Assay and Drug Development Technologies|August 3, 2013
A highly specific cell-based high-throughput screening assay for ligands of cyclic adenosine monophosphate receptor protein in gram-negative bacteriaHongxia Wang, Anisia J Silva, Lynn Rasmussen, et al.
Assay and Drug Development Technologies|December 24, 2011
Characterization of ligand binding to the σ(1) receptor in a human tumor cell line (RPMI 8226) and establishment of a competitive receptor binding assayStefanie Brune, Dirk Schepmann, Kirstin Lehmkuhl, et al.
Pageof 100